Discovery Life Sciences

Discovery Life Sciences is the global market leader in the analysis, procurement and distribution of biospecimens and a leading lab services organization specializing in genomic, cellular and histology-based scientific services and related bioinformatics for the pharmaceutical, biotechnology and diagnostics industries. Water Street merged Conversant Bio, Discovery Life Sciences and Folio Bio to create the company in 2018. Shortly thereafter, Discovery launched a major expansion in Europe to cement its position as a global leader. In 2019, the company added the renowned Genomic Services Laboratory of the HudsonAlpha Institute for Biotechnology and acquired Qualtek Molecular Laboratories. Today, Discovery offers a uniquely powerful suite of solutions that includes one of the world's largest commercial biorepositories and biospecimen networks, the HudsonAlpha Discovery sequencing and bioinformatics laboratory, and innovative flow cytometry and cell-based laboratory services. Water Street is working closely with Discovery's management team, led by CEO Glenn Bilawsky, to further grow Discovery's offering .

Subscribe to Water Street News

To receive Water Street news via email,
please complete the form below.

Privacy Policy

You’ve just been sent an email to confirm your email address. Please click on the link in the email to activate your subscription.

If you do not receive an email from us within a few minutes, please check your spam folder. If our email did not come through to you, please click on this link, news@waterstreet.com